David W. Mullins

6.9k citations
90 papers · 5.0k · 2 hit papers · h-index 34

Impact in

  • Accounting top 0.5%
    • Corporate Finance and Governance
    • Auditing, Earnings Management, Governance
  • Finance top 0.5%
    • Financial Markets and Investment Strategies

Papers in

    • Immunotherapy and Immune Responses 23
    • T-cell and B-cell Immunology 15
    • Immune cells in cancer 9
    • Immune Cell Function and Interaction 7
    • Cancer Immunotherapy and Biomarkers 10
    • Cytokine Signaling Pathways and Interactions 7

David W. Mullins

85 papers receiving 4.6k citations

David W. Mullins's Hit Papers

Equity issues and offering dilution 1986 · 1.0k citations
1.0k0+14+28Years since publication2505007501000

Peers

David W. Mullins
Comparison fields: 5 of 144
  • Accounting 1.9k
  • Finance 1.5k
  • Immunology 1.6k
  • Strategy and Management 762
  • Oncology 1.1k
Replace Daniel E. Kaufmann with:
Daniel E. Kaufmann United States
David E. Weinstein United States
David Miles United Kingdom
Robert E. Scott United States
Fred H. Allen United States
Peter Wright United States
Michael C. Jensen United States
Ashraf Khan United States
David Emanuel United States
Robert A. Schwartz United States
David W. Mullins relative to Daniel E. Kaufmann United States Daniel E. Kaufmann's profile →
Citations per field
00.5×5.7×
Daniel E. Kaufmann · 1×
Citations per year

Countries citing papers authored by David W. Mullins

Since Specialization
Citations

This map shows the geographic impact of David W. Mullins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Mullins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Mullins more than expected).

Fields of papers citing papers by David W. Mullins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Mullins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Mullins. The network helps show where David W. Mullins may publish in the future.

Co-authors

The 25 scholars most cited alongside David W. Mullins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David W. Mullins Line = papers co-authored together David W. Mullins links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Equity issues and offering dilution
Hit paper breakdown →
19861042
2
The gains to bidding firms from merger
Hit paper breakdown →
1983700
3 1998333
4 1986245
5 2003168
6 2000135
7 2004118
8 2017118
9 2012107
10 2002106
11 2003100
12 199999
13 201180
14 200579
15 200173
16 201468
17 200659
18 201058
19 201457
20 201253

About David W. Mullins

David W. Mullins is a scholar working on Immunology, Oncology, Molecular Biology, Finance and Epidemiology, having authored 90 papers that have together received 5.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (23 papers), Housing, Finance, and Neoliberalism (18 papers), T-cell and B-cell Immunology (15 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immune cells in cancer (9 papers), Cytokine Signaling Pathways and Interactions (7 papers), Immune Cell Function and Interaction (7 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Accounting (1.9k citations), Finance (1.5k citations), Immunology (1.6k citations), Strategy and Management (762 citations) and Oncology (1.1k citations). David W. Mullins has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Paul Asquith, Robert F. Bruner, Klaus D. Elgert, Víctor H. Engelhard, Timothy N. J. Bullock, David G. Alleva, Teresa A. Colella, Carol J. Burger, Steven Fiering and Craig L. Slingluff. Their work appears in journals such as The Journal of Immunology, Cancer Immunology Immunotherapy, Housing Studies, Cancer Immunology Research and The Journal of Finance.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact